Should patient groups accept money from drug companies? Yes.

Kent, Alastair · BMJ · 2007

Level V

Where this comes from

Abstract

Patient groups provide valuable support and advocacy for vulnerable people but funding the work can be difficult.<b> Alastair Kent </b>argues that not accepting industry money will unnecessarily limit the groups' effectiveness, but <b>Barbara Mintzes</b> believes that the money undermines their independence

Medical subject headings